Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology-Central Austin Cancer Center
mi
from
Austin, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology-Central Austin Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology
mi
from
Bedord, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology
mi
from
Bedord, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center At Medical City
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center At Medical City
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology, PA
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Baylor Sammons Cancer Center
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Baylor Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology Sammons Cancer Center
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center
mi
from
Denton, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center
mi
from
Denton, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology PA
mi
from
Garland, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology PA
mi
from
Garland, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology
mi
from
Houston, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology, PA at Lake Vista Cancer Center
mi
from
Lewisville, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology, PA at Lake Vista Cancer Center
mi
from
Lewisville, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Longview Cancer Center
mi
from
Longview, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Longview Cancer Center
mi
from
Longview, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
South Texas Cancer Center
mi
from
McAllen, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
South Texas Cancer Center
mi
from
McAllen, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center of Mesquite
mi
from
Mesquite, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center of Mesquite
mi
from
Mesquite, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology
mi
from
Midland, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology
mi
from
Midland, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology - Odessa
mi
from
Odessa, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology - Odessa
mi
from
Odessa, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Paris Regional Cancer Center Lab
mi
from
Paris, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Paris Regional Cancer Center Lab
mi
from
Paris, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center - Sherman
mi
from
Sherman, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center - Sherman
mi
from
Sherman, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology Cancer Center - Sugar Land
mi
from
Sugar Land, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology Cancer Center - Sugar Land
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Tyler Cancer Center
mi
from
Tyler, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Tyler Cancer Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology Cancer Care And Research Center
mi
from
Waco, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology Cancer Care And Research Center
mi
from
Waco, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Deke Slayton Cancer Center
mi
from
Webster, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Deke Slayton Cancer Center
mi
from
Webster, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Salem, VA
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Puget Sound Cancer Centers
mi
from
Edmonds, WA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Puget Sound Cancer Centers
mi
from
Edmonds, WA
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Puget Sound Cancer Centers
mi
from
Seattle, WA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Puget Sound Cancer Centers
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Cancer Care Northwest
mi
from
Spokane, WA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Cancer Care Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Northwest Cancer Specialists
mi
from
Vancouver, WA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Yakima Valley Memorial Hospital/North Star Lodge
mi
from
Yakima, WA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Yakima Valley Memorial Hospital/North Star Lodge
mi
from
Yakima, WA
Click here to add this to my saved trials
Phase 1 Trial of Oral Ixabepilone
A Phase 1 Study of Ixabepilone Administered as 3 Oral Doses Each Separated by 6 Hours Every 21 Days in Subjects With Advanced Cancer
Status: Enrolling
Updated:  2/9/2016
Stanford University
mi
from
Stanford, CA
Phase 1 Trial of Oral Ixabepilone
A Phase 1 Study of Ixabepilone Administered as 3 Oral Doses Each Separated by 6 Hours Every 21 Days in Subjects With Advanced Cancer
Status: Enrolling
Updated: 2/9/2016
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Phase 1 Trial of Oral Ixabepilone
A Phase 1 Study of Ixabepilone Administered as 3 Oral Doses Each Separated by 6 Hours Every 21 Days in Subjects With Advanced Cancer
Status: Enrolling
Updated:  2/9/2016
Georgetown University Medical Center
mi
from
Washington,
Phase 1 Trial of Oral Ixabepilone
A Phase 1 Study of Ixabepilone Administered as 3 Oral Doses Each Separated by 6 Hours Every 21 Days in Subjects With Advanced Cancer
Status: Enrolling
Updated: 2/9/2016
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Parallel Phase I Study of Ixabepilone Plus Lapatinib and Ixabepilone Plus Lapatinib Plus Capecitabine in Subjects With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Parallel Phase I Study of Ixabepilone Plus Lapatinib and Ixabepilone Plus Lapatinib Plus Capecitabine in Subjects With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Parallel Phase I Study of Ixabepilone Plus Lapatinib and Ixabepilone Plus Lapatinib Plus Capecitabine in Subjects With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Brisbane,
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Parallel Phase I Study of Ixabepilone Plus Lapatinib and Ixabepilone Plus Lapatinib Plus Capecitabine in Subjects With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Brisbane,
Click here to add this to my saved trials
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  2/9/2016
Georgetown University Medical Center
mi
from
Washington,
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 2/9/2016
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  2/9/2016
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 2/9/2016
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  2/9/2016
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 2/9/2016
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  2/9/2016
Local Institution
mi
from
Lucca,
Phase I Combination Ixabepilone + Cisplatin
Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 2/9/2016
Local Institution
mi
from
Lucca,
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Audie L Murphy Veterans Affairs Hospital
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Audie L Murphy Veterans Affairs Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated:  2/10/2016
University Hospital
mi
from
San Antonio, TX
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer
Status: Enrolling
Updated: 2/10/2016
University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study in Advanced Solid Tumors
Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  2/10/2016
Highlands Oncology Group, P.A.
mi
from
Fayetteville, AR
Study in Advanced Solid Tumors
Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/10/2016
Highlands Oncology Group, P.A.
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Study in Advanced Solid Tumors
Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  2/10/2016
University of Kansas Medical Center
mi
from
Fairway, KA
Study in Advanced Solid Tumors
Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/10/2016
University of Kansas Medical Center
mi
from
Fairway, KA
Click here to add this to my saved trials
Study in Advanced Solid Tumors
Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  2/10/2016
VA Sierra Nevada Health Care System
mi
from
Reno, NV
Study in Advanced Solid Tumors
Phase 2 Study to Evaluate the Pharmacokinetics and Drug-Drug Interaction of Cetuximab and Cisplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/10/2016
VA Sierra Nevada Health Care System
mi
from
Reno, NV
Click here to add this to my saved trials